These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 15010863)
1. IL2-dependent phosphorylation of 40S ribosomal protein S6 is controlled by PI-3K/mTOR signalling in CTLL2 cells. Tuhácková Z; Sloncová E; Vojtechová M; Sovová V Int J Mol Med; 2004 Apr; 13(4):601-5. PubMed ID: 15010863 [TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival. Chandrasekher G; Sailaja D Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065 [TBL] [Abstract][Full Text] [Related]
3. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062 [TBL] [Abstract][Full Text] [Related]
4. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport. Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949 [TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661 [TBL] [Abstract][Full Text] [Related]
6. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. Salh B; Wagey R; Marotta A; Tao JS; Pelech S J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729 [TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Navé BT; Ouwens M; Withers DJ; Alessi DR; Shepherd PR Biochem J; 1999 Dec; 344 Pt 2(Pt 2):427-31. PubMed ID: 10567225 [TBL] [Abstract][Full Text] [Related]
8. Initiation factor eIF2B not p70 S6 kinase is involved in the activation of the PI-3K signalling pathway induced by the v-src oncogene. Vojtechová M; Sloncová E; Kucerová D; Jiricka J; Sovová V; Tuhácková Z FEBS Lett; 2003 May; 543(1-3):81-6. PubMed ID: 12753910 [TBL] [Abstract][Full Text] [Related]
9. Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid. Kam Y; Exton JH FASEB J; 2004 Feb; 18(2):311-9. PubMed ID: 14769825 [TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase. Tang X; Wang L; Proud CG; Downes CP Biochem J; 2003 Aug; 374(Pt 1):137-43. PubMed ID: 12747804 [TBL] [Abstract][Full Text] [Related]
11. Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms. Somwar R; Sumitani S; Taha C; Sweeney G; Klip A Am J Physiol; 1998 Oct; 275(4):E618-25. PubMed ID: 9755080 [TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Cao X; Kambe F; Moeller LC; Refetoff S; Seo H Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791 [TBL] [Abstract][Full Text] [Related]
13. Involvement of the Akt/mTOR pathway on EGF-induced cell transformation. Nomura M; He Z; Koyama I; Ma WY; Miyamoto K; Dong Z Mol Carcinog; 2003 Sep; 38(1):25-32. PubMed ID: 12949840 [TBL] [Abstract][Full Text] [Related]
14. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Burgering BM; Coffer PJ Nature; 1995 Aug; 376(6541):599-602. PubMed ID: 7637810 [TBL] [Abstract][Full Text] [Related]
15. EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway. Chiu T; Santiskulvong C; Rozengurt E Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G182-94. PubMed ID: 15358595 [TBL] [Abstract][Full Text] [Related]
16. Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db/db mice. Hinault C; Mothe-Satney I; Gautier N; Lawrence JC; Van Obberghen E FASEB J; 2004 Dec; 18(15):1894-6. PubMed ID: 15479767 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641 [TBL] [Abstract][Full Text] [Related]
18. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms. Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340 [TBL] [Abstract][Full Text] [Related]
19. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain. Yu J; Henske EP Cancer Res; 2006 Oct; 66(19):9461-6. PubMed ID: 17018601 [TBL] [Abstract][Full Text] [Related]
20. In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism. Pellegatta F; Catapano AL; Luzi L; Terruzzi I J Cardiovasc Pharmacol; 2006 May; 47(5):643-9. PubMed ID: 16775502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]